This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
pathway Info Card
Synaptic Vesicle Targeting
Information about Synaptic Vesicle Targeting: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Synaptic Vesicle Targeting
Most recent studies have shown that Synaptic Vesicle Targeting shares some biological mechanisms with endocytosis, localization, secretion, transport, vesicle-targeting.
Among the many pathways, these few ones have gauged particular interests from scientists studying Synaptic Vesicle Targeting, and have been seen in publications frequently: endocytosis, localization, secretion, transport, vesicle-targeting
Quite a number of genes have been found to play important roles in Synaptic Vesicle Targeting, such as AP3B1, AQP2, CLCN3, SLC18A3, SLC2A4, SLC30A3, SNAP23, SNAP25, STX1A, SYP, VAMP2, VAMP3. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this pathway. Plesae stay updated.
Diseases Related to Synaptic Vesicle Targeting
This information is being compiled and will come in a future update
| adrenal gland neoplasms | chimera disorder | pheochromocytoma |
Related pathways
| endocytosis | localization | secretion |
| transport | vesicle targeting |